Compare PGNY & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PGNY | HTGC |
|---|---|---|
| Founded | 2008 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.9B |
| IPO Year | 2019 | 2004 |
| Metric | PGNY | HTGC |
|---|---|---|
| Price | $27.45 | $17.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $26.50 | $18.86 |
| AVG Volume (30 Days) | 995.3K | ★ 1.5M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 12.13% |
| EPS Growth | 14.04 | ★ 14.91 |
| EPS | 0.63 | ★ 0.90 |
| Revenue | ★ $1,288,661,000.00 | N/A |
| Revenue This Year | $8.87 | $11.18 |
| Revenue Next Year | $9.76 | $5.24 |
| P/E Ratio | $42.90 | ★ $19.48 |
| Revenue Growth | ★ 10.40 | N/A |
| 52 Week Low | $16.10 | $13.70 |
| 52 Week High | $33.07 | $19.62 |
| Indicator | PGNY | HTGC |
|---|---|---|
| Relative Strength Index (RSI) | 51.50 | 55.37 |
| Support Level | $25.16 | $15.17 |
| Resistance Level | $27.56 | $19.05 |
| Average True Range (ATR) | 0.78 | 0.28 |
| MACD | 0.29 | -0.04 |
| Stochastic Oscillator | 82.28 | 42.95 |
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.